Drugs / anthocyanins
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03415503 | Oct 2018 → Oct 2019 | hyperlipidemia | Sun Yat-sen University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anthocyanins | “In a randomized double-blinded placebo-controlled trial, 176 eligible dyslipidemia subjects were randomly assigned into four groups receiving placebo, 40, 80, or 320 mg/day...” PMID 33131908 ↗ Oct 2020 |
| Known as | Medox Anthocyanin capsules | “Medox® Anthocyanin capsules is consisted of 17 different natural purified anthocyanins.from bilberry (Vaccinium myrtillus) and black currant (Ribesnigrum).” NCT03415503 ↗ |
| Route | Oral | “Subjects were orally administered Medox® capsules daily for 12 weeks.” NCT03415503 ↗ |